Evidence map›Paper›PMID 41576085›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Molecular architecture and diversity of StopGo/2A translational recoding.

Xueyan Li, Philipp K Zuber, Gary Loughran, Pramod R Bhatt, Fatema Alquraish, V Ramakrishnan, Andrew E Firth, John F Atkins

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. RNAViruses · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xueyan Li *Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.ORCID 0000-0003-2251-710X
Philipp K Zuber *Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.ORCID 0000-0001-5139-3930
Gary LoughranSchool of Biochemistry and Cell Biology, University College Cork, Cork T12 XF62, Ireland.ORCID 0000-0002-2683-5597
Pramod R BhattSchool of Biochemistry and Cell Biology, University College Cork, Cork T12 XF62, Ireland.
Fatema AlquraishSchool of Biochemistry and Cell Biology, University College Cork, Cork T12 XF62, Ireland.
V RamakrishnanStructural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Andrew E FirthDepartment of Pathology/Division of Virology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.
John F AtkinsStructural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.ORCID 0000-0001-7933-0165

Funding

Deutsche Akademie der Naturforscher Leopoldina - Nationale Akademie der Wissenschaften (German National Academy of Sciences) LPDS 2021-14European Molecular Biology Organization (EMBO) ALTF 778-2021European Molecular Biology Organization (EMBO) ALTF 937-2022Irish Research Council (IrishResearch) IRCLA/2019/74UKRI | Medical Research Council (MRC) MC_U105184332Wellcome TrustWellcome Trust (WT) 220814/Z/20/ZWellcome Trust (WT) WT096570
6 · The paper itself

Abstract

Viral 2A sequences trigger a cotranslational peptide bond formation "skipping" event, termed "StopGo," to generate two separate proteins from a single open reading frame without classical termination. To investigate the mechanism of StopGo, we determined the cryo-EM structure of a mammalian ribosome positioned at the foot-and-mouth disease virus 2A (F2A) site. The structure shows how interactions between the F2A nascent chain (NC) and the ribosomal exit tunnel induce a conformational change in the peptidyl transferase center that precludes further translation elongation but instead pre-exposes the P-tRNA:F2A-NC ester bond for hydrolysis and NC release. Additionally, we bioinformatically characterized variation and host association across nearly 10,000 StopGo sequences identified in virus genomes. We expanded the canonical core motif to (D/G/C/N)(V/I)ExNPGP and identified additional rare but functional variants. We also revealed several distinct upstream motifs that we showed biochemically to be important for StopGo activity. Interestingly, although StopGo is known to be functionally active in plants, we found no evidence for natural utilization of StopGo by plant viruses. Overall, these findings provide valuable insights into a unique translation recoding mechanism, and lay foundations for further optimization of multigene expression in biotechnology.

Indexed as

Foot-and-Mouth Disease VirusProtein BiosynthesisViral ProteinsAnimalsCryoelectron MicroscopyModels, MolecularOpen Reading FramesRibosomesViral Proteinsvirus protein 2A2A sequence variationfoot-and-mouth disease virusnascent peptide interactionStopGotranslation recoding

Identifiers

PMID41576085
PMCPMC12846837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.